Cargando…

Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs

AIMS: In clinical practice, many patients do not reach the recommended treatment targets for LDL-cholesterol levels. We aimed to examine treatment patterns and adherence for patients on lipid lowering drugs in Norway to inform future strategies to improve therapies. METHODS AND RESULTS: We obtained...

Descripción completa

Detalles Bibliográficos
Autores principales:	Engebretsen, Ingrid, Munkhaugen, John, Bugge, Christoffer, Halvorsen, Sigrun, Ødegaard, Kristina Malene, Støvring, Henrik, Kristiansen, Ivar Sønbø
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683394/ https://www.ncbi.nlm.nih.gov/pubmed/36440353 http://dx.doi.org/10.1093/ehjopen/oeac070

Ejemplares similares

Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study
por: Bugge, Christoffer, et al.
Publicado: (2018)

What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
por: Bugge, Christoffer, et al.
Publicado: (2021)

Decisions on statin therapy by patients’ opinions about survival gains: cross sectional survey of general practitioners
por: Halvorsen, Peder A., et al.
Publicado: (2015)

A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
por: Ødegaard, Kristina Malene, et al.
Publicado: (2022)

Practice variation in surgical procedures and IUD-insertions among general practitioners in Norway – a longitudinal study
por: Pahle, Andreas Saxlund, et al.
Publicado: (2017)

Effect of organised mammography screening on stage-specific incidence in Norway: population study
por: Lousdal, Mette L, et al.
Publicado: (2016)

Phase- and gender-specific, lifetime, and future costs of cancer: A retrospective population-based registry study
por: Bugge, Christoffer, et al.
Publicado: (2021)

Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
por: Wisløff, Torbjørn, et al.
Publicado: (2012)

Simple parametric survival analysis with anonymized register data: A cohort study with truncated and interval censored event and censoring times
por: Støvring, Henrik, et al.
Publicado: (2011)

Negative controls to detect uncontrolled confounding in observational studies of mammographic screening comparing participants and non-participants
por: Lousdal, Mette Lise, et al.
Publicado: (2020)

Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway
por: Burger, Emily A, et al.
Publicado: (2017)

What professional activities do general practitioners find most meaningful? Cross sectional survey of Norwegian general practitioners
por: Halvorsen, Peder Andreas, et al.
Publicado: (2013)

Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016
por: Ødegaard, Kristina Malene, et al.
Publicado: (2020)

Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014–2020
por: Ødegaard, Kristina Malene, et al.
Publicado: (2022)

Evaluating costs and health consequences of sick leave strategies against pandemic and seasonal influenza in Norway using a dynamic model
por: Edwards, Christina Hansen, et al.
Publicado: (2019)

Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey
por: Harmsen, Charlotte Gry, et al.
Publicado: (2012)

Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice
por: Harmsen, Charlotte Gry, et al.
Publicado: (2013)

The impact of methicillin-resistant S. aureus on length of stay, readmissions and costs: a register based case-control study of patients hospitalized in Norway
por: Andreassen, A. Elizabeth S., et al.
Publicado: (2017)

Diabetes: cost of illness in Norway
por: Solli, Oddvar, et al.
Publicado: (2010)

Incidence in pharmacoepidemiology: A conceptual framework for incidence of a single substance or group of substances with statins as an example
por: Hoffmann, Mikael, et al.
Publicado: (2022)

Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave
por: Xue, Yiting, et al.
Publicado: (2010)

Dynamic modelling of costs and health consequences of school closure during an influenza pandemic
por: Xue, Yiting, et al.
Publicado: (2012)

Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?
por: Stovring, Henrik, et al.
Publicado: (2008)

Norwegian Physicians' Knowledge of and Opinions about Evidence-Based Medicine: Cross-Sectional Study
por: Ulvenes, Lidziya Vanahel, et al.
Publicado: (2009)

A multistate transition model for statin‐induced myopathy and statin discontinuation
por: Zhu, Yuxi, et al.
Publicado: (2021)

Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013–19
por: Jortveit, Jarle, et al.
Publicado: (2022)

Statin discontinuation: counterbalancing the benefits with the potential risks
por: Paraskevas, Kosmas I., et al.
Publicado: (2011)

Statin discontinuation in persons with and without Alzheimer’s disease
por: Vu, Mai, et al.
Publicado: (2022)

Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects
por: Peersen, Kari, et al.
Publicado: (2021)

The prevalence of hereditary neuromuscular disorders in Northern Norway
por: Müller, Kai Ivar, et al.
Publicado: (2020)

Use of Statins in Kidney Transplant Recipients in Norway
por: Rønning, Marit, et al.
Publicado: (2022)

The healthcare costs of treating human papillomavirus-related cancers in Norway
por: Hylin, Hannah, et al.
Publicado: (2019)

Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway
por: Jortveit, Jarle, et al.
Publicado: (2021)

Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey
por: Dahl, Rasmus, et al.
Publicado: (2007)

Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67
por: Desser, Arna S, et al.
Publicado: (2010)

Dynamic Modeling of Cost-effectiveness of Rotavirus Vaccination, Kazakhstan
por: Freiesleben de Blasio, Birgitte, et al.
Publicado: (2014)

The Coronavirus Pandemic and Lessons Learned in Preschools in Norway, Sweden and the United States: OMEP Policy Forum
por: Pramling Samuelsson, Ingrid, et al.
Publicado: (2020)

Lower‐Intensity Statins Contributing to Gaps in Care for Patients With Primary Severe Hypercholesterolemia
por: Eid, Wael E., et al.
Publicado: (2021)

Statins: the high risks of discontinuation and large benefits of continuation
por: Hennekens, Charle H., et al.
Publicado: (2011)

Deprescribing in Hospice Patients: Discontinuing Aspirin, Multivitamins, and Statins
por: Low, Cari E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k1m1v4qat00o4munrpjblnu95b